1.The physiological effects of resveratrol and its potential application in high altitude medicine.
Hui-li ZHU ; Hong-jing NIE ; Pei-bing LI ; Bing-nan DENG ; Rui-feng DUAN ; Hong JIN ; Zhao-li CHEN
Chinese Journal of Applied Physiology 2015;31(6):498-503
Resveratrol, as a natural polyphenolic compound, has a wide range of beneficial effects, which includes anti-tumor, cardiovascular protection, anti-oxidant and estrogen-like effects, and so on. Its various physiological properties are closely related to the therapeutic principle for prevention and treatment of high altitude hypoxia injury. Resveratrol may play an important role in relieving or curing high altitude diseases, especially high altitude polycythemia(HAPC). However, the literature about study and application of resveratrol in plateau medicine field is rarely reported up to now. In this review, we summarized the physiological effects of resveratrol, discussed the possible main principle of resveratrol for HAPC therapy, and looked forward to resveratrol's perspective or potential application in high altitude medicine.
Altitude
;
Humans
;
Hypoxia
;
drug therapy
;
Polycythemia
;
drug therapy
;
Stilbenes
;
pharmacology
5.The research progress of high altitude environment-associated chronic obstructive pulmonary disease and therapeutic drugs.
Xiang-Hai ZENG ; Ge-Le SUONAN ; Qin HUANG ; Yu LI ; Xiao-Jing ZHANG ; Wen-Bin LI ; Rong WANG
Acta Physiologica Sinica 2023;75(5):691-702
The plateau environment is characterized by low oxygen, low air pressure, low temperature, and strong ultraviolet rays, etc. Chronic obstructive pulmonary disease (COPD) is a preventable and treatable chronic lung disease. High altitude environment increases COPD prevalence, clinical manifestation and mortality. The therapeutic window of theophylline drugs for COPD is narrow, and the high altitude environment has an influence on the pharmacokinetics of the drugs. This review summarizes the differences in the prevalence, mortality, clinical manifestation and clinical symptoms of COPD in the plateau and plain, providing a basis for identifying the risk factors of COPD in the plateau areas. The effects of plateau hypoxic environment on the pharmacokinetics of COPD drugs were also discussed. It can provide a rationale for more effective prevention and treatment of COPD at high altitude.
Humans
;
Altitude
;
Pulmonary Disease, Chronic Obstructive/drug therapy*
;
Oxygen
;
Hypoxia
7.Recent advances in the study of bioreductive drugs targeted tumor hypoxia.
Jing-Bao LIU ; Lei FU ; Yong-Zhou HU ; Fa-Qin JIANG
Acta Pharmaceutica Sinica 2009;44(7):695-702
Tumor hypoxia is the necessary process in the development of solid tumors, which is the key factor for drug resistance, recurrence, attack and shift of tumor. Hypoxic tumor cells have a certain extent of tolerance to radiation and chemotherapy. Tumor hypoxia is an important target for medication therapy. In the recent years, the bioreductive drugs targeted tumor hypoxia has made great process in the treatment of tumors. The latest advances of bioreductive drugs targeted hypoxia were reviewed in this paper.
Antineoplastic Agents
;
therapeutic use
;
Cell Hypoxia
;
Humans
;
Hypoxia
;
Neoplasms
;
drug therapy
;
Quinones
;
therapeutic use
;
Reducing Agents
;
therapeutic use
8.Oxygen reserve index: a new parameter for oxygen therapy.
Chinese Journal of Contemporary Pediatrics 2022;24(11):1275-1280
Oxygen reserve index (ORI) is a novel dimensionless index used for noninvasive, real-time, and continuous monitoring of oxygenation, and ORI value ranges from 0 to 1, which reflects the range of 100-200 mmHg for arterial partial pressure of oxygen. ORI combined with pulse oximetry may help to accurately adjust the concentration of inspired oxygen and prevent hyperoxemia and hypoxemia. ORI is suitable for various clinical situations, and the medical staff should master this novel parameter and use it properly to assess the oxygenation of patients. In addition, several limitations of ORI should be noticed during clinical application.
Humans
;
Oxygen
;
Blood Gas Analysis
;
Oxygen Inhalation Therapy
;
Oximetry
;
Hypoxia/therapy*
9.A neonatal intelligent regulation system based on the combination of mild hypothermia mattress and hyperbaric oxygen chamber: introduction to a patent.
Ming-Xing ZHU ; Jun-Yu JI ; Xin WANG ; Shi-Xiong CHEN ; Wei-Min HUANG
Chinese Journal of Contemporary Pediatrics 2023;25(1):86-90
Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease that affects brain function in neonates. At present, mild hypothermia and hyperbaric oxygen therapy are the main methods for the treatment of neonatal HIE; however, they are independent of each other and cannot be combined for synchronous treatment, without monitoring of brain function-related physiological information. In addition, parameter setting of hyperbaric oxygen chamber and mild hypothermia mattress relies on the experience of the medical practitioner, and the parameters remain unchanged throughout the medical process. This article proposes a new device for the treatment of neonatal HIE, which has the modules of hyperbaric oxygen chamber and mild hypothermic mattress, so that neonates can receive the treatment of hyperbaric oxygen chamber and/or mild hypothermic mattress based on their conditions. Meanwhile, it can realize the real-time monitoring of various physiological information, including amplitude-integrated electroencephalogram, electrocardiogram, and near-infrared spectrum, which can monitor brain function, heart rate, rhythm, myocardial blood supply, hemoglobin concentration in brain tissue, and blood oxygen saturation. In combination with an intelligent control algorithm, the device can intelligently regulate parameters according to the physiological information of neonates and give recommendations for subsequent treatment.
Infant, Newborn
;
Humans
;
Hypothermia, Induced/methods*
;
Hypothermia/therapy*
;
Hyperbaric Oxygenation
;
Brain
;
Electroencephalography
;
Hypoxia-Ischemia, Brain/therapy*
10.Intermittent hypoxic preconditioning relieves fear and anxiety behavior in post-traumatic stress model mice.
Fu-Sheng DING ; Xiang CHENG ; Tong ZHAO ; Yong-Qi ZHAO ; Guang-Bo ZHANG ; Hai-Tao WU ; Ling-Ling ZHU ; Kui-Wu WU
Acta Physiologica Sinica 2019;71(4):537-546
Intermittent hypoxia (IH) has preventive and therapeutic effects on hypertension, myocardial infarction, cerebral ischemia and depression, but its effect on post-traumatic stress disorder (PTSD) has not been known. In this study, we used inescapable electric foot shock combined with context recapture to build PTSD mouse model. The levels of fear and anxiety were valued by the open field, the elevated plus maze (EPM) and the fear conditioning tests; the level of spatial memory was valued by Y maze test; the number of Fos positive neurons in hippocampus, amygdala and medial prefrontal cortex was valued by immunohistochemical staining; and the protein expressions of hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and brain derived neurotrophic factor (BDNF) in these brain area were valued by Western blot. The results showed that IH and model (foot shock) had an interaction on percentage of entering open arms (OE%) in EPM and freezing time and the number of fecal pellets in fear conditioning test. IH increased OE% in EPM and reduced the freezing time and the number of fecal pellets in fear conditioning test in PTSD model mice. At the same time, IH reduced the number of Fos positive neurons in the hippocampus, amygdala and medial prefrontal cortex of PTSD model mice, and increased the protein expression levels of HIF-1α, VEGF and BDNF in these brain tissues. In conclusion, IH pretreatment can relieve fear and anxiety behavior in post-traumatic stress model mice, suggesting that IH may be an effective means of preventing PTSD.
Animals
;
Anxiety
;
therapy
;
Brain-Derived Neurotrophic Factor
;
metabolism
;
Fear
;
Hypoxia
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
metabolism
;
Mice
;
Stress Disorders, Post-Traumatic
;
therapy
;
Vascular Endothelial Growth Factor A
;
metabolism